Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4644675
Max Phase: Preclinical
Molecular Formula: C49H55ClF2N12O11
Molecular Weight: 1061.50
Molecule Type: Unknown
Associated Items:
ID: ALA4644675
Max Phase: Preclinical
Molecular Formula: C49H55ClF2N12O11
Molecular Weight: 1061.50
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C1CCC(N2C(=O)c3cccc(NCCOCCOCCOCCOCCn4cc(CCCC(=O)N[C@@H]5CCN(c6ncc(C(=O)Nc7ccc(OC(F)(F)Cl)cc7)cc6-c6cc[nH]n6)C5)nn4)c3C2=O)C(=O)N1
Standard InChI: InChI=1S/C49H55ClF2N12O11/c50-49(51,52)75-35-9-7-32(8-10-35)57-45(67)31-27-37(38-13-15-55-60-38)44(54-28-31)62-17-14-33(29-62)56-41(65)6-1-3-34-30-63(61-59-34)18-20-72-22-24-74-26-25-73-23-21-71-19-16-53-39-5-2-4-36-43(39)48(70)64(47(36)69)40-11-12-42(66)58-46(40)68/h2,4-5,7-10,13,15,27-28,30,33,40,53H,1,3,6,11-12,14,16-26,29H2,(H,55,60)(H,56,65)(H,57,67)(H,58,66,68)/t33-,40?/m1/s1
Standard InChI Key: PSIJYAOLNAWKKI-DGRXGLRRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1061.50 | Molecular Weight (Monoisotopic): 1060.3770 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Yang Y, Gao H, Sun X, Sun Y, Qiu Y, Weng Q, Rao Y.. (2020) Global PROTAC Toolbox for Degrading BCR-ABL Overcomes Drug-Resistant Mutants and Adverse Effects., 63 (15): [PMID:32657579] [10.1021/acs.jmedchem.0c00967] |
Source(1):